Growth momentum Rare Patient Voice has demonstrated sustained growth, highlighted by expansion into Oceania in 2022 and a presence on the Inc. 5000 list in 2022, indicating a scalable model and proven market demand that can be leveraged to upsell larger, international research programs.

Acquisition momentum Recent news confirms strategic interest from a larger analytics player, Konovo Insights, acquiring Rare Patient Voice in 2026, suggesting the value of their patient recruitment capabilities and a potential channel for formal partnership discussions or transition opportunities.

High patient engagement The company has paid patients over 15 million dollars since 2013, underscoring strong participant incentives, reliable turnout, and a mature monetization model that can appeal to clients needing robust recruitment for diverse conditions.

Global reach With operations extending to Australia and New Zealand, plus established workflows through thousands of patient advocacy groups, there is an opportunity to position as a global recruitment partner for multinational studies demanding diverse patient panels.

Industry positioning Serving as a focused Research Services provider specialized in patient and caregiver perspectives, Rare Patient Voice sits among mid-market recruitment firms with comparable peers; this presents a doorway to cross-sell adjacent services such as study design input, advisory support, or expanded recruitment for rare disease programs.